GSK plc (FRA:GS71)

GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of EUR 75.99 billion. The enterprise value is 91.25 billion.

Market Cap	75.99B
Enterprise Value	91.25B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	4.02B
Shares Outstanding	n/a
Shares Change (YoY)	+0.49%
Shares Change (QoQ)	-0.65%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	90.35%
Float	3.89B

Valuation Ratios

The trailing PE ratio is 19.03 and the forward PE ratio is 9.45.

PE Ratio	19.03
Forward PE	9.45
PS Ratio	2.06
PB Ratio	4.54
P/TBV Ratio	n/a
P/FCF Ratio	10.16
P/OCF Ratio	8.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of 12.20.

EV / Earnings	22.85
EV / Sales	2.51
EV / EBITDA	8.37
EV / EBIT	12.49
EV / FCF	12.20

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.21.

Current Ratio	0.87
Quick Ratio	0.56
Debt / Equity	1.21
Debt / EBITDA	1.83
Debt / FCF	2.71
Interest Coverage	10.25

Financial Efficiency

Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 12.75%.

Return on Equity (ROE)	28.33%
Return on Assets (ROA)	6.78%
Return on Invested Capital (ROIC)	12.75%
Return on Capital Employed (ROCE)	16.38%
Revenue Per Employee	537,683
Profits Per Employee	58,186
Employee Count	68,629
Asset Turnover	0.54
Inventory Turnover	1.50

Taxes

In the past 12 months, GSK plc has paid 744.29 million in taxes.

Income Tax	744.29M
Effective Tax Rate	13.80%

Stock Price Statistics

The stock price has increased by +8.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.62%
50-Day Moving Average	17.61
200-Day Moving Average	17.06
Relative Strength Index (RSI)	64.82
Average Volume (20 Days)	1,615

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of EUR 36.90 billion and earned 3.99 billion in profits. Earnings per share was 0.96.

Revenue	36.90B
Gross Profit	26.45B
Operating Income	7.43B
Pretax Income	5.39B
Net Income	3.99B
EBITDA	10.84B
EBIT	7.43B
Earnings Per Share (EPS)	0.96

Balance Sheet

The company has 4.22 billion in cash and 20.25 billion in debt, giving a net cash position of -16.02 billion.

Cash & Cash Equivalents	4.22B
Total Debt	20.25B
Net Cash	-16.02B
Net Cash Per Share	n/a
Equity (Book Value)	16.75B
Book Value Per Share	4.26
Working Capital	-3.16B

Cash Flow

In the last 12 months, operating cash flow was 9.01 billion and capital expenditures -1.53 billion, giving a free cash flow of 7.48 billion.

Operating Cash Flow	9.01B
Capital Expenditures	-1.53B
Free Cash Flow	7.48B
FCF Per Share	n/a

Margins

Gross margin is 71.69%, with operating and profit margins of 20.13% and 10.82%.

Gross Margin	71.69%
Operating Margin	20.13%
Pretax Margin	14.61%
Profit Margin	10.82%
EBITDA Margin	29.37%
EBIT Margin	20.13%
FCF Margin	20.27%

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 3.93%.

Dividend Per Share	0.75
Dividend Yield	3.93%
Dividend Growth (YoY)	7.50%
Years of Dividend Growth	1
Payout Ratio	72.80%
Buyback Yield	-0.49%
Shareholder Yield	3.45%
Earnings Yield	5.26%
FCF Yield	9.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 19, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 1.83 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.83
Piotroski F-Score	6